Print this page

Income Statement 

XLS

EUR million

2nd Quarter
2010

2nd Quarter
2009

Jan.–June
2010

Jan.–June
2009

*

Figures for 2009 have been adjusted for the disclosure of commission income as well as royalty and commission expenses

Sales

2,102.8

1,826.4

4,125.6

3,583.3

Royalty and commission income*

105.2

83.4

181.3

184.9

Total revenues

2,208.0

1,909.7

4,306.9

3,768.2

 

 

 

 

 

Cost of sales

–517.2

–517.7

–1,003.9

–974.5

Gross margin

1,690.8

1,392.0

3,303.0

2,793.7

 

 

 

 

 

Marketing and selling expenses*

–540.2

–466.7

–1,008.4

–920.6

Royalty and commission expenses*

–117.3

–101.2

–239.5

–198.6

Administration expenses

–115.2

–108.1

–219.6

–214.9

Other operating expenses and income

–109.4

–44.7

–244.4

–129.8

Research and development

–338.8

–340.6

–686.0

–653.5

Amortization of intangible assets

–145.9

–146.3

–286.4

–293.8

Investment result

2.2

0.1

2.2

0.1

Operating result

326.2

184.5

621.0

382.6

 

 

 

 

 

Exceptional items

–1.2

–1.2

–68.8

Earnings before interest and tax (EBIT)

325.0

184.5

619.8

313.8

 

 

 

 

 

Financial result

–78.3

–36.3

–116.9

–71.3

Profit before tax

246.8

148.2

502.9

242.5

 

 

 

 

 

Income tax

–59.9

–38.3

–121.4

–72.4

Profit after tax

186.9

109.9

381.5

170.1

 

 

 

 

 

Non-controlling interest

–3.5

–1.4

–6.6

–5.0

Net profit after non-controlling interest

183.4

108.5

374.8

165.1

 

 

 

 

 

Earnings per share (in EUR)

 

 

 

 

basic

0.84

0.50

1.72

0.76

diluted

0.84

0.50

1.72

0.76

© Merck KGaA, Darmstadt, Germany, Last Update 2010/07/29